FindTrial
Sign In

Evaluation of the quality of life of coffee producers in Poço Fundo-MG with the SF-36 instrument during the covid-19 pandemic

Evaluation of the quality of life of coffee growers in Poço Fundo-MG with the SF-36 instrument during the covid-19 pandemic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3dcb3jy
Enrollment
Unknown
Registered
2021-11-19
Start date
2021-01-04
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers, Surveys and Questionnaires

Interventions

Application of the SF-36 instrument via an online questionnaire to 50 volunteers during the COVID-19 pandemic in coffee growers of the COOPFAM cooperative in the city of Poço Fundo-MG via an online qu
28608
I01.800
D012423

Sponsors

UNISEPE - Uniao Das Instituicoes De Servico Ensino e Pesquisa
Lead Sponsor
UNISEPE - Uniao Das Instituicoes De Servico Ensino e Pesquisa
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Coffee growers participating in the WhatsApp group of the company COOPFAM; over 18 years; both sexes and who agree to participate in the survey by asking about their consent.

Exclusion criteria

Exclusion criteria: Individuals who are not coffee growers; individuals who do not understand the reading and interpretation of the questionnaire.

Design outcomes

Primary

MeasureTime frame
The application of the SF-36 questionnaire is expected to assess the general health of the population studied and the health according to the domains of the SF-36 questionnaire.—

Secondary

MeasureTime frame
It is expected to address the health problems found in the application of the SF-36 questionnaire and to offer a better quality of life to rural workers.—

Countries

Brazil

Contacts

Public ContactRoberta de Oliveira Silva
robs1006oliveira@gmail.com+55(35)99936-2355

Outcome results

None listed

Source: REBEC (via WHO ICTRP)